In our results, FOXO3 was demonstrated to suppress the transcription of RASIP1 by binding to its promoter −690/-683 sequence, and the suppressive effects of FOXO3 on DLBCL cell behaviors were reversed by RASIP1. Here, RASIP1 is linked to diffuse large B-cell lymphoma.